<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Teva Pharmaceutical Industries News</title>
<link>http://www.inboxrobot.com/news/teva-pharmaceutical-industries</link>
<description>Constantly updated news and information about a variety of topics.</description><item>
<title>UBS warns on Israeli shares: The bank is pessimistic on the local economy, and on corporate profits as well.</title>
<link>http://www.inboxrobot.com/news.php?fid=207225023</link>
<pubDate>9 Jan 2009 02:28 GMT</pubDate>
<description>
...  less than the consensus for telecommunications companies. It agrees with the consensus only for Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA). UBS assumes that both Israel Chemicals Ltd. (TASE:  ...
</description>
</item><item>
<title>Stars &amp; Society</title>
<link>http://www.inboxrobot.com/news.php?fid=207184259</link>
<pubDate>8 Jan 2009 21:50 GMT</pubDate>
<description>
...  Bill Martha doesn&#39;t need a happy pill to celebrate his company&#39;s latest acquisition: Israel&#39;s Teva Pharmaceutical Industries Ltd. -- of which Martha is head of its North American division, with  ...
</description>
</item><item>
<title>UPDATE 1-Teva says major acquisition unlikely soon</title>
<link>http://www.inboxrobot.com/news.php?fid=207152031</link>
<pubDate>8 Jan 2009 18:33 GMT</pubDate>
<description>
... NEW YORK, Jan 8 (Reuters) - Teva Pharmaceutical Industries Ltd ( ) is unlikely to make a big acquisition in the near  ...
</description>
</item><item>
<title>UPDATE 1-Tel Aviv shares dip 3 pct, Lebanon tensions weigh</title>
<link>http://www.inboxrobot.com/news.php?fid=207147714</link>
<pubDate>8 Jan 2009 18:28 GMT</pubDate>
<description>
...  0.1 percent, with traders noting a slight recovery in commodities prices was underpinning ICL. Teva Pharmaceutical Industries was 0.6 percent lower, with some support from a stronger dollar. Losses were  ...
</description>
</item><item>
<title>Teva to Present at the 27th Annual J.P. Morgan Healthcare Conference</title>
<link>http://www.inboxrobot.com/news.php?fid=207114190</link>
<pubDate>8 Jan 2009 15:28 GMT</pubDate>
<description>
... JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NASDAQ: ) will host a live audio webcast at the 27th Annual  ...
</description>
</item><item>
<title>Codexis signs licensing agreement with Teva</title>
<link>http://www.inboxrobot.com/news.php?fid=207113775</link>
<pubDate>8 Jan 2009 15:05 GMT</pubDate>
<description>
...  -- Codexis, a developer of proprietary custom biocatalysts, has signed a licensing agreement with Teva Pharmaceutical Industries to produce an important publicly-undisclosed generic product, using a proprietary Codexis biocatalyst. Under  ...
</description>
</item><item>
<title>Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.</title>
<link>http://www.inboxrobot.com/news.php?fid=207099895</link>
<pubDate>8 Jan 2009 13:53 GMT</pubDate>
<description>
...  of microRNA-based molecular diagnostics, announced today it has signed an exclusive distribution agreement with Teva Pharmaceutical Industries Ltd. Under the terms of the agreement Teva will offer Rosetta Genomics&#39; miRview(TM)  ...
</description>
</item><item>
<title>Ratiopharm to go under the hammer as Merckle gets loan</title>
<link>http://www.inboxrobot.com/news.php?fid=207083403</link>
<pubDate>8 Jan 2009 12:02 GMT</pubDate>
<description>
...  $1.8 billion euros, and is sure to attract a lot of interest. Unsurprisingly, Israels Teva Pharmaceutical Industries is seen as a frontrunner to acquire the Berlin-based group. However research-based pharmaceutical  ...
</description>
</item><item>
<title>Tel Aviv shares dip as Lebanon rockets hit Israel</title>
<link>http://www.inboxrobot.com/news.php?fid=207081051</link>
<pubDate>8 Jan 2009 11:31 GMT</pubDate>
<description>
...  percent but traders noted that a slight recovery in commodities prices was underpinning ICL. Teva Pharmaceutical Industries was 0.4 percent lower, with some support from a stronger dollar. Losses were  ...
</description>
</item><item>
<title>ExCell Study Joined By Children&#39;s Memorial Hospital, Chicago</title>
<link>http://www.inboxrobot.com/news.php?fid=207071692</link>
<pubDate>8 Jan 2009 10:31 GMT</pubDate>
<description>
...  a Joint Venture equally owned and managed by Jerusalem-based biomedical company Gamida Cell and Teva Pharmaceutical Industries (NASDAQ: TEVA). For many patients suffering from blood-based cancers such as leukemia and  ...
</description>
</item><item>
<title>Teva Elects Amir Elstein to Its Board</title>
<link>http://www.inboxrobot.com/news.php?fid=207049996</link>
<pubDate>8 Jan 2009 07:31 GMT</pubDate>
<description>
... Jan 07, 2009 (Close-Up Media via COMTEX) -- Teva Pharmaceutical Industries announced that Amir Elstein has joined the Company&#39;s board of directors. Elstein has  ...
</description>
</item><item>
<title>Codexis announces licensing agreement with Teva Pharmaceutical Industries</title>
<link>http://www.inboxrobot.com/news.php?fid=207046416</link>
<pubDate>8 Jan 2009 07:26 GMT</pubDate>
<description>
... Codexis, Inc. today announced a licensing agreement with Teva Pharmaceutical Industries Ltd., to produce an important publicly-undisclosed generic product, using a proprietary Codexis biocatalyst.  ...
</description>
</item><item>
<title>Teva to Present at the Goldman Sachs Healthcare CEOs...</title>
<link>http://www.inboxrobot.com/news.php?fid=207028003</link>
<pubDate>8 Jan 2009 05:26 GMT</pubDate>
<description>
...  10 minutes before). An archive of the webcast will be available on Teva&#39;s website. Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the  ...
</description>
</item><item>
<title>Moody&#39;s affirms Teva Pharma debt rating</title>
<link>http://www.inboxrobot.com/news.php?fid=207028001</link>
<pubDate>8 Jan 2009 05:26 GMT</pubDate>
<description>
... NEW YORK (AP) - Moody&#39;s Investors Service said Tuesday it affirmed its rating on Teva Pharmaceutical Industries Ltd. and upgraded the credit facilities of Barr Laboratories, which Teva acquired last  ...
</description>
</item><item>
<title>BRIEF: Teva could buy Germany&#39;s Ratiopharm</title>
<link>http://www.inboxrobot.com/news.php?fid=206976502</link>
<pubDate>7 Jan 2009 22:26 GMT</pubDate>
<description>
...  2009 (Globes - McClatchy-Tribune Information Services via COMTEX News Network) -- Reuters reports that Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) is thought to be the most likely buyer  ...
</description>
</item></channel>
</rss>
